Market Narratives
Market themes driving price action · Updated Apr 16, 2026
Silicon Valley immigration impact
An article belongs to this narrative if it discusses the impact of immigration on the tech industry, particularly in Silicon Valley.
Left-wing nonprofit boss virtue signaling Cuba trip
An article belongs to this narrative if it discusses a left-wing nonprofit boss's controversial travel or spending decisions.
Geopolitical risks and opportunities in oil and Iran
An article belongs to this narrative if it discusses geopolitical risks and opportunities in the oil market related to Iran.
Small loan market growth opportunities
An article belongs to this narrative if it discusses the market for small loans and borrowing options.
IIG potential acquisition by AC8
An article belongs to this narrative if it discusses the potential acquisition of Intuitive Investments Group by Acceler8 Ventures.
Novozymes expands Thailand footprint
An article belongs to this narrative if it covers Novozymes' acquisition of a production facility in Thailand.
Allogene Therapeutics ALPHA3 trial progress
An article belongs to this narrative if it discusses Allogene Therapeutics' progress in its ALPHA3 trial for cemacabtagene ansegedleucel.
Healthcare services stocks decline on moving average breaches
An article belongs to this narrative if it discusses declines in healthcare services stocks due to moving average breaches.
DA Davidson reiterates Buy rating on AXOS Financial
An article belongs to this narrative if it discusses DA Davidson's rating or price target for Axos Financial.
DLO Breaks $1 Billion Revenue Milestone
An article belongs to this narrative if it discusses DLocal's (DLO) revenue milestone of surpassing $1 billion.
SGL Carbon Q4 earnings
An article belongs to this narrative if it discusses SGL Carbon's Q4 earnings results.
MCHP launches new cybersecurity platform
An article belongs to this narrative if it discusses Microchip Technology Inc.'s (MCHP) introduction of a new cybersecurity platform.
SiTime Corporation Santa Clara expansion
An article belongs to this narrative if it discusses SiTime Corporation's expansion and lease signing for two buildings in Santa Clara.
Aardvark Therapeutics ARD-101 trial pause
An article belongs to this narrative if it discusses Aardvark Therapeutics' voluntary pause of its ARD-101 trials.
Allogene Therapeutics cemacabtagene ansegedleucel trial progress
An article belongs to this narrative if it discusses Allogene Therapeutics' progress in its cemacabtagene ansegedleucel trial.
Silicon Laboratories and BANF In-Tire Sensor Platform Introduction
An article belongs to this narrative if it discusses Silicon Laboratories' and BANF's introduction of an in-tire sensor platform.
PAAS_La_Colorada_Silver_Mine_Expansion
An article belongs to this narrative if it discusses Pan American Silver Corp.'s (PAAS) plans to expand its La Colorada silver mine into the world's …
META delays Avocado AI rollout
An article belongs to this narrative if it discusses Meta Platforms' delay in launching its new foundational AI model, Avocado.
HALO_Interim_CFO_Appointment_Growth_Plans
An article belongs to this narrative if it discusses Halozyme Therapeutics' (HALO) appointment of an interim CFO amidst growth plans.
Congress considers ban on stock trading, impacting ETFs
An article belongs to this narrative if it discusses proposed legislation that would ban members of Congress from trading individual stocks, impacting related ETFs.
CNBC_Bloomberg_Peter_Tchir_Market_Economist_To_Military_Strategist
An article belongs to this narrative if it discusses Peter Tchir's role change from market economist to military strategist on TV shows like CNBC and …
Peter Tchir joins Academy Securities as market economist
An article belongs to this narrative if it discusses the career change of Peter Tchir to Academy Securities as a market economist.
AKVA strategic review for potential sale or combinations
An article belongs to this narrative if it discusses AKVA Group's strategic review process, which may result in a potential sale or value-creating business combinations.
Pulmonary hypertension treatment advances
An article belongs to this narrative if it discusses new treatments, trials, or breakthroughs in pulmonary hypertension.